Você está na página 1de 2

ALPCO Announces Inaugural Young Investigators Award Recipient

ALPCO announces the first recipient of its new young investigators award, the Diabetes Research
Travel Grant.

Salem, NH, October 17, 2018 --(PR.com)-- ALPCO, a leading producer of research and clinical
immunoassays, announced the first recipient of its new young investigators award, the Diabetes Research
Travel Grant. The grant was created to help advance progressive diabetes and obesity research by
graduate students, postdoctoral fellows, and early stage investigators. The program seeks to stimulate and
reward research applicable to the investigation and eventual development of diabetes and obesity
treatments, therapies and/or innovations.

ALPCO awarded its inaugural Diabetes Research Travel Grant to Stephen M. Grote from the Saint Louis
University School of Medicine. Mr. Grote's work with the novel peptide neuronostatin shows great
promise to the diabetes research community. His research suggests that neuronostatin has an effect on
glucagon synthesis and release, while also proposing that the peptide may have therapeutic potential in
the treatment and prevention of hypoglycemia and alpha cell dysfunction in diabetes.

“We created the Diabetes Research Travel Grant to recognize innovative young investigators working at
the forefront of diabetes research,” explains ALPCO's president, Sean Conley. “We found Mr. Grote's
work on neuronostatin to be not only compelling, but also in alignment with future insights into the
therapeutic potential of the peptide which could significantly reduce the occurrence of hypoglycemic
events.”

Visit alpco.com to learn more about Mr. Grote's research and ALPCO's young investigators award,
including the Diabetes Research Travel Grant.

About ALPCO
American Laboratory Products Company (ALPCO) was founded in 1991 as an importer and distributor of
immunoassay products for the North American life science markets. The company has since evolved into
a premier developer and manufacturer of immunoassay-based in vitro diagnostic reagents. Today,
ALPCO offers a wide range of unique testing solutions, providing both research scientists and healthcare
professionals with vital tools for advancing research and improving quality of care.

Page 1/2
PR.com Press Release Distribution Terms of Use
Contact Information:
ALPCO
Christiann Cailouette
1-800-592-5726
Contact via Email
www.alpco.com

Online Version of Press Release:


You can read the online version of this press release at: https://www.pr.com/press-release/767711

News Image:

Page 2/2
PR.com Press Release Distribution Terms of Use

Você também pode gostar